Kraig Biocraft Laboratories, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) develops and commercializes protein-based fibers, including recombinant spider silk and high-performance polymers, using recombinant DNA technology and genetically engineered domesticated mulberry silkworms; its core proprietary technologies encompass natural and engineered spider silk variants such as BAM-1 hybrid, BAM-1 Alpha, and advanced Generation III platforms employing non-CRISPR gene editing with large plasmid knock-in knock-out methods for producing nearly pure spider silk customized for strength, flexibility, and other properties; products target performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, ballistic protection for military and police, geotextiles, protective clothing, transportation and building textiles, and functional sportive textiles. The company, founded in 2006 and headquartered in Ann Arbor, Michigan, operates primarily in the United States with production facilities including two rearing centers in a leading global silk production region managed through its wholly owned subsidiary Prodigy Silk, alongside the Prodigy Textile brand as a DBA. Recent developments include securing a $10 million standby equity purchase agreement with YA II PN (Yorkville) in January 2025 to fund production expansion, inventory buildup, consumer product development, and sales partnerships over 36 months; achieving record spider silk output in a single early 2025 production run surpassing all of 2024's combined production; launching a second parallel production facility, a diapausing silkworm system, and three new spider silk strains including replacements for BAM-1 lines to enhance yield and premium quality for high-end textile markets; accelerating operations into two purpose-built commercial rearing centers by August 2025 with equipment transfers from the original pilot facility; initiating a sixth 2025 production cycle in October featuring large-scale BAM-1 Alpha deployment; pursuing an additional rearing center; nearing a three-year government collaboration for hybridized silkworm scaling; and launching a significant hiring initiative in November 2025 to support next-generation technology expansion.
Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview
Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle
Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications
The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer
The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer
Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up
Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race
Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output
Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk
Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons
The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future
From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle
From Genetic Puzzle to Industrial Platform